1. Home
  2. CDNA vs ATRC Comparison

CDNA vs ATRC Comparison

Compare CDNA & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$20.58

Market Cap

712.2M

Sector

Health Care

ML Signal

HOLD

Logo AtriCure Inc.

ATRC

AtriCure Inc.

HOLD

Current Price

$42.26

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
ATRC
Founded
1998
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
712.2M
1.6B
IPO Year
2014
2005

Fundamental Metrics

Financial Performance
Metric
CDNA
ATRC
Price
$20.58
$42.26
Analyst Decision
Buy
Strong Buy
Analyst Count
7
9
Target Price
$26.00
$52.00
AVG Volume (30 Days)
816.3K
572.3K
Earning Date
11-04-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.22
N/A
Revenue
$357,998,000.00
$518,304,999.00
Revenue This Year
$14.11
$16.90
Revenue Next Year
$12.00
$12.29
P/E Ratio
$16.92
N/A
Revenue Growth
14.46
15.80
52 Week Low
$10.96
$28.29
52 Week High
$25.95
$43.11

Technical Indicators

Market Signals
Indicator
CDNA
ATRC
Relative Strength Index (RSI) 71.98 70.06
Support Level $18.36 $38.92
Resistance Level $19.95 $42.42
Average True Range (ATR) 0.86 1.67
MACD 0.19 0.63
Stochastic Oscillator 99.42 94.89

Price Performance

Historical Comparison
CDNA
ATRC

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Share on Social Networks: